[Intestinal trematodiases (metagonimiasis, nanophyetiasis): clinico-parasitological research and the first trial of using Azinox in a focus of the lower Amur River valley].
A focus of metagonimiasis and nanophyetiasis is described with the average human prevalence of 66.7 and 4.2%, respectively and low intensity of invasions (less than 100 eggs per 1 g). Metagonimiasis and nanophyetiasis are clinically expressed as chronic enterocolitis. A high effect of a single dose 10 mg/kg of azinox against metagonimiasis (98%) and nanophyetiasis (100%) was shown. The treatment course was proved to be useful in the foci of the Amur basin.
Bronshteĭn
A M
AM
Korablev
V N
VN
Iarotskiĭ
L S
LS
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D002648:Child; D002675:Child, Preschool; D004197:Disease Reservoirs; D004341:Drug Evaluation; D005243:Feces / Q000469:parasitology; D005260:Female; D006578:Heterophyidae; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy / Q000469:parasitology*; D008297:Male; D008875:Middle Aged; D010270:Parasite Egg Count; D011223:Praziquantel / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012800:Siberia; D014200:Trematoda; D014201:Trematode Infections / Q000188:drug therapy / Q000469:parasitology*
C078071:azinox; D011223:Praziquantel
Kishechnye trematodozy (metagonimoz, nanofietoz): kliniko-parazitologicheskoe issledovanie i pervyĭ opyt primeneniia azinoksa v ochage Nizhnego Priamur'ia.